Christopher R. McBurney

514 total citations
17 papers, 408 citations indexed

About

Christopher R. McBurney is a scholar working on Gastroenterology, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Christopher R. McBurney has authored 17 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Gastroenterology, 5 papers in Economics and Econometrics and 4 papers in Epidemiology. Recurrent topics in Christopher R. McBurney's work include Gastrointestinal motility and disorders (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Gastroesophageal reflux and treatments (2 papers). Christopher R. McBurney is often cited by papers focused on Gastrointestinal motility and disorders (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Gastroesophageal reflux and treatments (2 papers). Christopher R. McBurney collaborates with scholars based in United States, Switzerland and Canada. Christopher R. McBurney's co-authors include Suzanne M. Kelly, Robert Balshaw, Pierre Paré, James R. Gray, M Barbeau, Margaret C. Reilly, Mona L. Martin, Donald L. Patrick, Donald M. Bushnell and Victoria Barghout and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Gastroenterology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Christopher R. McBurney

17 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher R. McBurney United States 12 179 113 70 69 52 17 408
Pam Bridge United Kingdom 5 186 1.0× 78 0.7× 50 0.7× 23 0.3× 47 0.9× 8 354
Javier Júdez Spain 14 165 0.9× 115 1.0× 251 3.6× 30 0.4× 40 0.8× 49 638
M. Figueras Spain 9 94 0.5× 84 0.7× 118 1.7× 39 0.6× 58 1.1× 18 476
J DiCesare United States 7 563 3.1× 215 1.9× 75 1.1× 24 0.3× 166 3.2× 11 801
Roghayeh Mohammadibakhsh Iran 8 24 0.1× 27 0.2× 103 1.5× 28 0.4× 15 0.3× 16 264
M Wood United States 7 15 0.1× 30 0.3× 142 2.0× 44 0.6× 42 0.8× 9 404
E. Bardelli Italy 7 221 1.2× 180 1.6× 69 1.0× 13 0.2× 65 1.3× 10 441
Michel Kiflen Canada 7 41 0.2× 33 0.3× 31 0.4× 10 0.1× 61 1.2× 11 308
David Thomas Johnson Australia 5 12 0.1× 70 0.6× 29 0.4× 33 0.5× 26 0.5× 10 452
Rahim Sohrabi Iran 8 24 0.1× 28 0.2× 121 1.7× 6 0.1× 15 0.3× 17 302

Countries citing papers authored by Christopher R. McBurney

Since Specialization
Citations

This map shows the geographic impact of Christopher R. McBurney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. McBurney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. McBurney more than expected).

Fields of papers citing papers by Christopher R. McBurney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. McBurney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. McBurney. The network helps show where Christopher R. McBurney may publish in the future.

Co-authorship network of co-authors of Christopher R. McBurney

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. McBurney. A scholar is included among the top collaborators of Christopher R. McBurney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. McBurney. Christopher R. McBurney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Balshaw, Robert, et al.. (2009). Longitudinal Outcomes of GastroIntestinal symptoms in Canada (LOGIC): key factors for an effective patient retention in observational studies.. PubMed. 16(1). e140–50. 1 indexed citations
2.
Abetz, Linda, Diana Rofail, Polyxane Mertzanis, et al.. (2009). Alzheimer’s disease treatment: Assessing caregiver preferences for mode of treatment delivery. Advances in Therapy. 26(6). 627–644. 21 indexed citations
3.
4.
Ekman, Mattias, Jenny Berg, Anders Wimo, Linus Jönsson, & Christopher R. McBurney. (2006). Health utilities in mild cognitive impairment and dementia: a population study in Sweden. International Journal of Geriatric Psychiatry. 22(7). 649–655. 22 indexed citations
5.
6.
Willan, Andrew R., Ron Goeree, Eleanor Pullenayegum, Christopher R. McBurney, & Gordon Blackhouse. (2006). Economic Evaluation of Rivastigmine in Patients with Parkinson??s Disease Dementia. PharmacoEconomics. 24(1). 93–106. 15 indexed citations
7.
Montgomery, Stuart, John Doyle, Lee Stern, & Christopher R. McBurney. (2005). Economic Considerations in the Prescribing of Third-Generation Antidepressants. PharmacoEconomics. 23(5). 477–491. 11 indexed citations
8.
Reilly, Margaret C., Christopher R. McBurney, & A. Bracco. (2005). Responsiveness of the Work Productivity and Activity Impairment Questionnaire for Irritable Bowel Syndrome with Constipation (WPAI:IBS-C) to Clinically Meaningful Change. The American Journal of Gastroenterology. 100. S284–S284. 2 indexed citations
9.
Paré, Pierre, Robert Balshaw, Isabelle Morin, et al.. (2005). PO2 DEVELOPMENT AND VALIDATION OF A QUESTIONNAIRE TO EVALUATE SEVERITY OF SYMPTOMS IN PATIENTS WITH IBS-C AND IBS-A. Value in Health. 8(6). A8–A8. 2 indexed citations
10.
Reilly, Margaret C., Victoria Barghout, Christopher R. McBurney, & Timothy Niecko. (2005). Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation. Alimentary Pharmacology & Therapeutics. 22(5). 373–380. 28 indexed citations
11.
Paré, Pierre, Robert Balshaw, Paul Keown, et al.. (2005). Patient Characteristics Irritable Bowel Syndrome with Constipation (IBS-C). The American Journal of Gastroenterology. 100. S284–S285. 1 indexed citations
12.
McBurney, Christopher R., Kim A. Eagle, Eva Kline‐Rogers, et al.. (2004). Work‐Related Outcomes After a Myocardial Infarction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(11). 1515–1523. 19 indexed citations
13.
Smith, Dean G. & Christopher R. McBurney. (2003). An Economic Analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS). PharmacoEconomics. 21(Supplement 1). 13–23. 12 indexed citations
14.
McBurney, Christopher R., Kim A. Eagle, Eva Kline‐Rogers, et al.. (2002). Health‐Related Quality of Life in Patients 7 Months After a Myocardial Infarction: Factors Affecting the Short Form‐12. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(12). 1616–1622. 21 indexed citations
15.
Kline‐Rogers, Eva, et al.. (2002). Adherence with traditional medication and complementary and alternative medicine use six months after hospital discharge in patients with acute coronary syndromes. Journal of the American College of Cardiology. 39. 444–444. 1 indexed citations
16.
McBurney, Christopher R., et al.. (2002). Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate Staphylococcus aureus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(8). 983–989. 18 indexed citations
17.
Martin, Steven J., et al.. (2001). The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy. 47(5). 581–587. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pam Bridge Breakdown of academic impact, for papers by Javier Júdez Breakdown of academic impact, for papers by M. Figueras Breakdown of academic impact, for papers by J DiCesare Breakdown of academic impact, for papers by Roghayeh Mohammadibakhsh Breakdown of academic impact, for papers by M Wood Breakdown of academic impact, for papers by E. Bardelli Breakdown of academic impact, for papers by Michel Kiflen Breakdown of academic impact, for papers by David Thomas Johnson Breakdown of academic impact, for papers by Rahim Sohrabi
Rankless by CCL
2026